ELIZABETH BROWN: Open Payments
NPI 1801559307 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 9 payments from 7 companies in 2025. Trend: 2023 $228 · 2024 $107 · 2025 $259
Food & beverage: $147Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, ABILIFY ASIMTUFII, WAKIX, VRAYLAR, ABILIFY MAINTENA, COBENFY.
Industry payments across IN — which companies pay providers there.
